Jose L. Placido

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Benralizumab effectiveness in a real-world Portuguese severe eosinophilic asthma population: BETREAT study.

Benralizumab effectiveness in a real-world Portuguese severe eosinophilic asthma population: BETREAT study.

Journal: Pulmonology

Published: July 17, 2026

The Value of Patient-Reported Questionnaires in Detecting Ocular Surface Manifestations in Dupilumab Therapy: A Case-Control Study.

The Value of Patient-Reported Questionnaires in Detecting Ocular Surface Manifestations in Dupilumab Therapy: A Case-Control Study.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: July 07, 2025

A clinical update on chronic rhinosinusitis and nasal polyposis.

A clinical update on chronic rhinosinusitis and nasal polyposis.

Journal: European annals of allergy and clinical immunology

Published: April 24, 2025

Venom immunotherapy in clinical practice: comparison of two ultra-rush protocols.

Venom immunotherapy in clinical practice: comparison of two ultra-rush protocols.

Journal: European annals of allergy and clinical immunology

Published: September 02, 2024

Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma.

Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma.

Journal: European annals of otorhinolaryngology, head and neck diseases

Published: May 22, 2023

The impact of the COVID-19 pandemic in Hymenoptera venom immunotherapy: a single center experience.

The impact of the COVID-19 pandemic in Hymenoptera venom immunotherapy: a single center experience.

Journal: European annals of allergy and clinical immunology

Published: June 09, 2022

Vespa velutina nigrithorax venom allergy: Real-life clinical practice.

Vespa velutina nigrithorax venom allergy: Real-life clinical practice.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: June 07, 2022

COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.

COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.

Journal: Vaccines

Published: March 08, 2022

A case of protracted eosinopenia after a single subcutaneous dose of benralizumab.

A case of protracted eosinopenia after a single subcutaneous dose of benralizumab.

Journal: Allergo journal international

Published: February 10, 2022

Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments.

Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: November 23, 2021

Sensitization to bee venom in Portuguese non-allergic beekeepers.

Sensitization to bee venom in Portuguese non-allergic beekeepers.

Journal: European annals of allergy and clinical immunology

Published: June 25, 2021

FeNO testing in severe asthma: A clinical argument or an access constraint?

FeNO testing in severe asthma: A clinical argument or an access constraint?

Journal: Pulmonology

Published: April 09, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026